Nu Med Plus Stock Today
| NUMD Stock | USD 0.01 0 10.00% |
Performance0 of 100
| Odds Of DistressLess than 10
|
Nu Med is trading at 0.0126 as of the 22nd of December 2024, a 10 percent decrease since the beginning of the trading day. The stock's lowest day price was 0.0126. Nu Med has less than a 10 % chance of experiencing some financial distress in the next two years of operation, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 22nd of November 2024 and ending today, the 22nd of December 2024. Click here to learn more.
Nu-Med Plus, Inc., a medical device company, engages in the design, development, enhancement, and commercialization of medical devices worldwide. Nu-Med Plus, Inc. was incorporated in 2011 and is headquartered in Salt Lake City, Utah. Nu Med operates under Medical Devices classification in the United States and is traded on OTC Exchange. The company has 81.35 M outstanding shares. More on Nu Med Plus
Moving together with NUMD OTC Stock
Moving against NUMD OTC Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
NUMD OTC Stock Highlights
| Business Concentration | Medical Devices, Healthcare (View all Sectors) |
Nu Med Plus [NUMD] is traded as part of a regulated electronic over-the-counter service offered by the NASD. The company currently falls under 'Nano-Cap' category with a current market capitalization of 1.14 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Nu Med's market, we take the total number of its shares issued and multiply it by Nu Med's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Nu Med Plus conducts business under Healthcare sector and is part of Medical Devices industry. The entity has 81.35 M outstanding shares.
Nu Med Plus currently holds about 2.54 K in cash with (206.83 K) of positive cash flow from operations.
Check Nu Med Probability Of Bankruptcy
Ownership AllocationNu Med Plus secures a total of 81.35 Million outstanding shares. Nu Med Plus owns majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 61.99 % of Nu Med Plus outstanding shares that are owned by insiders conveys that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company retains, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check NUMD Ownership Details
Nu Med Plus Risk Profiles
| Mean Deviation | 7.37 | |||
| Standard Deviation | 11.94 | |||
| Variance | 142.62 | |||
| Risk Adjusted Performance | (0.07) |
NUMD Stock Against Markets
Picking the right benchmark for Nu Med otc stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Nu Med otc stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Nu Med is critical whether you are bullish or bearish towards Nu Med Plus at a given time. Please also check how Nu Med's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Nu Med without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Center Now
Portfolio CenterAll portfolio management and optimization tools to improve performance of your portfolios |
| All Next | Launch Module |
Nu Med Corporate Executives
Elected by the shareholders, the Nu Med's board of directors comprises two types of representatives: Nu Med inside directors who are chosen from within the company, and outside directors, selected externally and held independent of NUMD. The board's role is to monitor Nu Med's management team and ensure that shareholders' interests are well served. Nu Med's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Nu Med's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Keith Merrell | CFO, Secretary and Treasurer | Profile |
Other Information on Investing in NUMD OTC Stock
Nu Med financial ratios help investors to determine whether NUMD OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in NUMD with respect to the benefits of owning Nu Med security.